Home > Qtrly Results > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Quarterly Results Analysis [Sep2024]

ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Quarterly Results

Standalone Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Revenues ₹408 Cr ₹388 Cr ₹383 Cr ₹306 Cr ₹311 Cr ₹295 Cr ₹285 Cr ₹250 Cr
Expenses ₹355 Cr ₹349 Cr ₹334 Cr ₹291 Cr ₹258 Cr ₹228 Cr ₹225 Cr ₹213 Cr
Operating Income ₹53 Cr ₹38 Cr ₹49 Cr ₹15 Cr ₹53 Cr ₹67 Cr ₹60 Cr ₹37 Cr
Other Income ₹8 Cr ₹8 Cr ₹9 Cr ₹10 Cr ₹8 Cr ₹8 Cr ₹8 Cr ₹7 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹9 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr
Profit Before Tax ₹51 Cr ₹-15 Cr ₹54 Cr ₹20 Cr ₹73 Cr ₹71 Cr ₹23 Cr ₹39 Cr
Profit After Tax ₹38 Cr ₹-12 Cr ₹39 Cr ₹16 Cr ₹52 Cr ₹54 Cr ₹17 Cr ₹29 Cr
EPS ₹15.37 ₹-4.72 ₹15.79 ₹6.32 ₹20.95 ₹21.54 ₹6.91 ₹11.72
Industry Peers & Returns1W1M1Y
ASTRAZENECA PHARMA INDIA -1.9% -1.9% 19.3%
SUN PHARMACEUTICAL INDUSTRIES 2.9% 6.4% 48.1%
CIPLA 2.3% 1% 20.6%
DR REDDYS LABORATORIES 3.5% 15.7% 20.3%
ZYDUS LIFESCIENCES -0.1% 2.3% 41.1%
DIVIS LABORATORIES 0.5% -2.1% 59.2%
MANKIND PHARMA 2.5% 12.4% 50.8%
TORRENT PHARMACEUTICALS -0.8% 5.7% 54.3%
LUPIN 3.8% 11.1% 72.6%

ASTRAZENECA PHARMA INDIA Quarterly Revenues

Revenues
Q-o-Q

5.28 %

Y-o-Y

31.16 %

Quarters Revenues % Change
Sep2024 ₹408 Cr
5.28
Jun2024 ₹388 Cr
1.13
Mar2024 ₹383 Cr
25.31
Dec2023 ₹306 Cr
-1.70
Sep2023 ₹311 Cr
5.28
Jun2023 ₹295 Cr
3.78
Mar2023 ₹285 Cr
13.97
Dec2022 ₹250 Cr -

ASTRAZENECA PHARMA INDIA Quarterly Operating Profit

Operating Profit
Q-o-Q

38.01 %

Y-o-Y

-0.42 %

Quarters Operating Profit % Change
Sep2024 ₹53 Cr
38.01
Jun2024 ₹38 Cr
-22.92
Mar2024 ₹49 Cr
228.03
Dec2023 ₹15 Cr
-71.46
Sep2023 ₹53 Cr
-21.53
Jun2023 ₹67 Cr
12.35
Mar2023 ₹60 Cr
63.57
Dec2022 ₹37 Cr -
Operating Margins
Q-o-Q

31.16 %

Y-o-Y

-24.06 %

Quarters Operating Margin% % Change
Sep2024 12.88%
31.16
Jun2024 9.82%
-23.82
Mar2024 12.89%
161.99
Dec2023 4.92%
-70.99
Sep2023 16.96%
-25.48
Jun2023 22.76%
8.28
Mar2023 21.02%
43.48
Dec2022 14.65% -

ASTRAZENECA PHARMA INDIA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Positive

Y-o-Y

-26.62 %

Quarters Profit After Tax % Change
Sep2024 ₹38 Cr
Positive
Jun2024 ₹-12 Cr
Negative
Mar2024 ₹39 Cr
149.86
Dec2023 ₹16 Cr
-69.83
Sep2023 ₹52 Cr
-2.77
Jun2023 ₹54 Cr
211.85
Mar2023 ₹17 Cr
-41.07
Dec2022 ₹29 Cr -
PAT Margins
Q-o-Q

Positive

Y-o-Y

-44.06 %

Quarters PAT Margin(%) % Change
Sep2024 9.42 %
Positive
Jun2024 -3.04 %
Negative
Mar2024 10.3 %
99.23
Dec2023 5.17 %
-69.30
Sep2023 16.84 %
-7.62
Jun2023 18.23 %
200.33
Mar2023 6.07 %
-48.25
Dec2022 11.73 % -

ASTRAZENECA PHARMA INDIA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Positive

Y-o-Y

-26.63 %

Quarters EPS % Change
Sep2024 ₹15.37
Positive
Jun2024 ₹-4.72
Negative
Mar2024 ₹15.79
149.84
Dec2023 ₹6.32
-69.83
Sep2023 ₹20.95
-2.74
Jun2023 ₹21.54
211.72
Mar2023 ₹6.91
-41.04
Dec2022 ₹11.72 -

You may also like the below Video Courses